News -
NNIT A/S: 19/2015 Financial report for the first nine months of 2015
NNIT delivers organic revenue growth of 8.2% and an operating profit margin of 10.9% in constant currencies.
Performance highlights for the first nine months of 2015
- Revenue increased by 8.2% in constant currencies to DKK 1,862m and 9.0% in reported currencies to DKK 1,877m
- Operating profit margin was 10.9% in constant currencies and 9.4% in reported currencies. Reported operating profit was negatively impacted by currency headwind
- Operating profit increased by 15.3% to DKK 202m in constant currencies and operating profit in reported currencies increased by 0.7% to DKK 177m reflecting a negative impact from currency development
- Net profit increased by 4.7% to DKK 144m in reported currencies mainly due to improved net financials and lower tax
- Order backlog for 2015 at the beginning of Q4 2015 increased by 7.2% compared with order backlog for 2014 at the beginning of Q4 2014
Outlook for 2015 in constant currencies:
- Revenue in constant currencies is still forecasted to grow 6-8%, whereas revenue growth in reported currencies is expected to be around 0.8pp higher based on current exchange rates
- Operating profit margin is still forecasted to be around 11% in constant currencies, whereas operating profit margin in reported currencies is expected to be around 1.3pp lower based on current exchange rates
Per Kogut, CEO at NNIT comments: “I am pleased to report strong double-digit growth from our non-Novo Nordisk Group customers, including a 17.9% organic growth from other life sciences customers. Despite a competitive market we have still delivered robust operating profit, and are on track to reach our 2015 targets.”
Read more on the NNIT Investor site
Contacts for further information
Investor relations:
Jesper Vesterbæk Wagener
Head of Investor Relations
Tel: +45 3075 5392
Media relations:
Rikke Dalager
Head of Communications
Tel: +45 3077 8080